Blood Res.  2021 Dec;56(4):349-353. 10.5045/br.2021.2021197.

Therapy-related myeloid neoplasms after transcatheter arterial chemoembolization for hepatocellular carcinoma

Affiliations
  • 1Division of Hematology–Oncology, Department of Medicine, Chung-Ang University, Seoul, Korea
  • 2Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea


Reference

1. Swerdlow SH, Campo E, Harris NL, et al. 2017. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. IARC Press;Lyon, France:
2. Kayser S, Döhner K, Krauter J, et al. 2011; The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML. Blood. 117:2137–45. DOI: 10.1182/blood-2010-08-301713. PMID: 21127174.
Article
3. Cowell IG, Austin CA. 2012; Mechanism of generation of therapy related leukemia in response to anti-topoisomerase II agents. Int J Environ Res Public Health. 9:2075–91. DOI: 10.3390/ijerph9062075. PMID: 22829791. PMCID: PMC3397365.
Article
4. Granfeldt Østgård LS, Medeiros BC, Sengeløv H, et al. 2015; Epidemiology and clinical significance of secondary and therapy-related acute myeloid leukemia: a National Population-Based Cohort Study. J Clin Oncol. 33:3641–9. DOI: 10.1200/JCO.2014.60.0890. PMID: 26304885.
Article
5. Hulegårdh E, Nilsson C, Lazarevic V, et al. 2015; Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: a report from the Swedish Acute Leukemia Registry. Am J Hematol. 90:208–14. DOI: 10.1002/ajh.23908. PMID: 25421221.
Article
6. Sanz MA, Lo Coco F, Martín G, et al. 2000; Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood. 96:1247–53. PMID: 10942364.
7. Döhner H, Estey E, Grimwade D, et al. 2017; Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 129:424–47. DOI: 10.1182/blood-2016-08-733196. PMID: 27895058. PMCID: PMC5291965.
Article
8. Greenberg PL, Tuechler H, Schanz J, et al. 2012; Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 120:2454–65. DOI: 10.1182/blood-2012-03-420489. PMID: 22740453. PMCID: PMC4425443.
9. Cheson BD, Bennett JM, Kopecky KJ, et al. 2003; Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol. 21:4642–9. DOI: 10.1200/JCO.2003.04.036. PMID: 14673054.
Article
10. Cheson BD, Greenberg PL, Bennett JM, et al. 2006; Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood. 108:419–25. DOI: 10.1182/blood-2005-10-4149. PMID: 16609072.
Article
11. McNerney ME, Godley LA, Le Beau MM. 2017; Therapy-related myeloid neoplasms: when genetics and environment collide. Nat Rev Cancer. 17:513–27. DOI: 10.1038/nrc.2017.60. PMID: 28835720. PMCID: PMC5946699.
Article
12. Suzukawa M, Nakazora T, Kawasaki Y, Tominaga T, Shinohara K. 2010; Massive ascites associated with all-trans retinoic acid treatment in therapy-related acute promyelocytic leukemia. Intern Med. 49:457–60. DOI: 10.2169/internalmedicine.49.2733. PMID: 20190483.
Article
13. Park SH, Chi HS, Cho YU, Jang S, Park CJ. 2013; Evaluation of prognostic factors in patients with therapy-related acute myeloid leukemia. Blood Res. 48:185–92. DOI: 10.5045/br.2013.48.3.185. PMID: 24086938. PMCID: PMC3786278.
Article
14. Alexander SI, Smith N, Hu M, et al. 2008; Chimerism and tolerance in a recipient of a deceased-donor liver transplant. N Engl J Med. 358:369–74. DOI: 10.1056/NEJMoa0707255. PMID: 18216357.
Article
15. Litzow MR, Tarima S, Pérez WS, et al. 2010; Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood. 115:1850–7. DOI: 10.1182/blood-2009-10-249128. PMID: 20032503. PMCID: PMC2832815.
Full Text Links
  • BR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr